Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03507296
Other study ID # VAR2017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 13, 2018
Est. completion date September 25, 2020

Study information

Verified date October 2021
Source Haute Ecole de Santé Vaud
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will test the within and between day variability of spinal kinematics and trunk muscle activity in healthy subjects and chronic low back pain patients during various daily-life activities.


Description:

This study will test the within and between day variability of spinal kinematics and trunk muscle activity in healthy subjects and chronic low back pain patients during various daily-life activities. Participants will come twice to the motion laboratory. During the first session, participants will first perform different functional activities (V1), such as sit-to-stand, gait, lifting tasks, stepping up. Their spinal kinematics will be measured with a camera-based system (VICON) using a multi-segment spinal model and trunk muscles activity will be recorded with surface electromyography. After a break, participants will have to perform all the functional activities a second time (V2). These two measures (V1 and V2) will be used to determine the within day variability of spinal kinematics. Finally, all participants will come one week later (V3) to repeat all the measurements to determine the between day variability.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date September 25, 2020
Est. primary completion date September 25, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - sufficient French level to understand the instructions for the tests, the information sheet, the consent form and the questionnaires - All chronic low back pain patients should present with non-specific low back pain (pain from lower ribs to gluteal folds) for more than 3 months. Exclusion Criteria: - pregnancy - body mass index (BMI) that is above 32 - patients should not have any sign of specific low back pain such as the presence of infection, rheumatological or neurological diseases, spinal fractures, any known important spinal deformities, previous back surgery that limits spinal mobility, tumours - high level of pain at the time of experiment that prevents repeated movements (severity and irritability) - other concomitant pain or condition that could compromise the evaluation of spinal kinematics.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Switzerland University of Lausanne Hospitals Lausanne Vaud

Sponsors (1)

Lead Sponsor Collaborator
Haute Ecole de Santé Vaud

Country where clinical trial is conducted

Switzerland, 

References & Publications (2)

Christe G, Kade F, Jolles BM, Favre J. Chronic low back pain patients walk with locally altered spinal kinematics. J Biomech. 2017 Jul 26;60:211-218. doi: 10.1016/j.jbiomech.2017.06.042. Epub 2017 Jul 5. Erratum in: J Biomech. 2019 Jan 23;83:329. — View Citation

Christe G, Redhead L, Legrand T, Jolles BM, Favre J. Multi-segment analysis of spinal kinematics during sit-to-stand in patients with chronic low back pain. J Biomech. 2016 Jul 5;49(10):2060-2067. doi: 10.1016/j.jbiomech.2016.05.015. Epub 2016 May 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Spinal kinematics Range of movement at the lower lumbar, upper lumbar, lower thoracic and upper thoracic joints Change between measure 1 and measure 2 (30 minutes later)
Primary Trunk muscle activity Surface electromyography of paraspinal, rectus abdominis and external obliques muscles Change between measure 1 and measure 2 (30 minutes later)
Primary Spinal kinematics Range of movement at the lower lumbar, upper lumbar, lower thoracic and upper thoracic joints Change between measure 1 and measure 3 (day 7)
Primary Trunk muscle activity Surface electromyography of paraspinal, rectus abdominis and external obliques muscles Change between measure 1 and measure 3 (day 7)
Secondary Pain intensity Pain intensity will be quantified by the 11-point Numeric Pain Rating Scale. The scale range from 0 (no pain at all) to 10 (worst pain). Measure 1 (Day 0), Measure 3 (Day 7)
Secondary Disability Disability will be quantified by the Patient Specific Functional Scale. The scale assessed three relevant activities for the patient and scores each activity between 0 (impossible to realize the activity) to 10 (capable of doing the activity normally). Measure 1 (Day 0), Measure 3 (Day 7)
Secondary Disability (ODI) Oswestry Disability Questionnaire. Score between 0 (no disability) and 100. Measure 1 (Day 0), Measure 3 (Day 7).
Secondary Kinesiophobia Tampa Scale of Kinesiophobia. The total score is between 17 (no kinesiophobia) to 68 (high level of kinesiophobia). Measure 1 (Day 0), Measure 3 (Day 7).
Secondary Catastrophizing Pain Catastrophizing Scale. Score between 0 and 52 (high levels of catastrophizing). Measure 1 (Day 0), Measure 3 (Day 7).
Secondary Back Pain Attitudes Questionnaire Back Pain Attitudes Questionnaire. Score between 34 (positive attitudes) and 170 (negative attitudes) Measure 1 (Day 0), Measure 3 (Day 7).
Secondary Fear Fear scale measured before each movement or activity. Score between 0 (no fear) and 10 (high levels of fear). Measure 1 (Day 0), Measure 2 (Day 0), Measure 3 (Day 7).
Secondary Pain expectation Pain expectation scale before each movement or activity. Score between 0 (no pain expected) and 10 (high levels of pain expected). Measure 1 (Day 0), Measure 2 (Day 0), Measure 3 (Day 7).
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3